Long-Term Effect Of One Phase III Trial: Benefit For Thousands Of Patients
High Dose Radiotherapy Plus Chemo Encouraging For Small Cell Lung Cancer
Age Shouldn’t Determine Lung Cancer Treatment, ASCO Says In New Guideline
Patch-Lozenge Combination Best For Smoking Cessation
Lower Dose Dexamethasone Can Be Used To Treat Newly Diagnosed Myeloma
Low Total Cholesterol Linked To Higher Risk Of Cancer; Higher HDL Associated With Decreased Risk Of Cancer
Black-White Disparity Seen In End Of Life Treatment
HER2+ Tumors Increase Risk Of Recurrence, Study Finds
The Clinical Cancer Letter To End Print Edition In 2010
NCI Cooperative Group Clinical Trials Approved
Trending Stories
- Mt. Sinai forms committee to probe Epstein links to breast center founder Eva Dubin, other faculty members
- Lawsuits brought against Tempus AI raise more questions than answers about DNA privacy in the AI era
- Vinay Prasad, oncologist and Twitter star, locked in debate over precision medicine
- GRAIL presses on with Galleri test despite missed primary endpoint in pivotal study
Where GRAIL sees signals of benefit in the subgroups, screening experts see signs of overdiagnosis - Kim Rathmell named OSUCCC director, Pollock becomes director emeritus in planned leadership transition
- GRAIL’s Megan Hall: “I think we can be confident that there is clinical benefit to implementing this technology. And I think that’s really hard to argue with.”
Mainstream epidemiologists beg to differ
